Every living organism may get sick in deficiency or in biological invasion, humans too. Nature is indeed impartial. Alike pests for plants, there are clans for humans. Pharmaceuticals are the supplement or drug to keep humans healthy and going on. Keeping the whole life-cycles in picture, it should be precisely targeted, improving bioefficacy is our focus-area.

There is much more that happens at micro- and nano-scale, beyond humans cognitive capabilities that is crucial to understand while we are dealing with biochemistry. At Vraisense we help our partners in measuring activity and mapping pathways (when, where and how much) in complex matrices and enabling a product with better-specificity and precise-control reach to market, while improving the safety standards.

In the competitive world claims and actuaries might be different in different scenarios in the absence of optimal validation measures, no matter it is allopathic, homeopathic and ayurvedic, at Vraisense using imaging technologies we contribute in validation of bioefficaies, when and which one is more effective-, precise- and accurate-treatment. Even with all advancements, seeing the food habits, lifestyle, degradation of environmental and food-chain cycle, the diseases and malfunctions are compelling the significant growth of unhealthiness. Coronavirus pandemic is a recent example, health is much more than the possession of more and advance gadgets around.

Scientifically, in changing climate scenario humans have no ideal measures to assess and to predict when, how and where there would be an outbreak of newer disease, as they also evolve as humans do with biological cum artificial intelligence. Existing pharmaceuticals have the potential of meeting some of the increasing health challenges, the challenges are with the specificity and preciseness. And hence the role of allied innovations.

Considering the ratio of input (drug consumption) vs output (drug efficacy), both quantitatively and qualitatively, there is mamooth scope of improvements. Pharmaceutical research and manufacturers are facing constant pressure to include more technological interventions to improve on the characterisation of medicines that comply and fit more with the toxicological/clinical studies.

Ensuring high standards of drug-discovery and synthesis processes for better human health and the whole of the environment cycle, with more comprehensive and innovative strategies in place, became the need of the time. To comply with the health-oriented regulations upgradation around pharmaceutical drug or allied clinical trials, including the adversarial-effects and thresholds of residue levels, are no more an option than necessity. We, at Vraisense are technologically helping our partners in achieving the optimal control production and application settings, driven by the strictly regulated and continously monitored health standards, ensuring more safer options to revive and live again healthy.

At VraiSense, we are acting at the core of the research that multiplexes efficiently the science, technology and data in achieving the precise specificity settings and bioefficacy allied resource management. Our focus remains on developing data-driven strategies that significantly help in deciding when and which one is most suitable with what concentration.

We are collaborating with our partners for improving the pharmaceutical research and drug-discovery processes that enable better options for humans to opt for being healthy. We have great agility to collaborate seamlessly for improving the characterisation of pharmaceutical-drug with a bit more closer and deeper insights, and helping in improving its quality and allied treatments.

Please feel free to collaborate on technology-driven scientific and innovational approaches that assist products to match and meet the scientific and regulatory principles, throughout the risk/benefit assessment. We have collective experience in collaborating projects in improving the assessment of the activities and pathways of active pharmaceutical ingredients with a focus on improving accuracy and precision of multi-dimensional bioefficacy.